Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)

C. Gutner, S. Dakhia, M. Gill, M. Pascual-Bernaldez, B. Hernandez, A. Rami, J. Portilla, T. Lutz, M. van der Valk, E. Florence, N. Barnes, O. Cooper, D. Filipenko, A. Hamilton, M. Bosse, M. Czarnogorski

Research output: Contribution to journalConference abstract in journal

Original languageEnglish
JournalHIV Medicine
Pages (from-to)114-115
Number of pages2
Publication statusPublished - 2021

Cite this